Market sentiment signals for Aprea Therapeutics (APRE): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
4 analysts
Options Flow (P/C)
—
Avg Consensus PT
$3
+414.1%
Highest Price Target
$5
+818.0%
Lowest Price Target
$1
+120.3%
Short Interest
4.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | Ladenburg Thalmann | Kevin DeGeeter— | +267.2% | $2 | Initiate | Buy |
| Aug 13, 2026 | Wedbush | Robert Driscoll— | +450.8% | $6 → $3 | Maintained | Outperform |
